Composition for preventing or treating vascular permeability disease comprising imatinib or pharmaceutically acceptable salts thereof as active ingredient

The invention vessel using a double sheet tinip or vascular permeability pharmaceutical for the treatment or prevention of related diseases compositions and the composition comprising a pharmaceutically acceptable salt thereof as an active ingredient that has been used for the treatment of chronic myelogenous leukemia with the conventional transmissive-associated diseases It relates to a method of treating. Vascular permeability-related treatment or prevention a pharmaceutical composition for a disease of the present invention, including a double sheet tinip that has been used for the treatment of a conventional CML of the active ingredient, as well as providing a new use of the double sheet tinip, vascular permeability-related diseases so it can effectively treat or prevent, could be widely used to develop new treatments of vascular permeability disorders.